Ovarian cancer Cancer Malignant neoplasm of ovary
Conditions
Interventions
Current information as of 11/08/2009:
At the end of chemotherapy those who have consented to the study will be asked to complete a Hospital Anxiety and Depression Scale (HADS) to assess their suitabi
Sponsors
Department of Health (UK)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Current information as of 11/08/2009: 1. Patients newly diagnosed with ovarian cancer, attending the outpatient clinic of Dr G Jayson 2. Age <55 years 3. Written informed consent 4. Hospital Anxiety and Depression Scale (HADS) score of 7 Initial information at time of registration: Patients with ovarian cancer, who are less than 55 years of age, will be giving an information sheet outlining the study.
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Added 11/08/2009: Women in both arms of the study will be assessed using: 1. HADS and Worry About Cancer Scale 2. A Social Support Inventory (SSI) 3. an Impact of Events Scale 4. A scale assessing the beliefs about controllability and social worry These will be administered at the end of chemotherapy and 3 months following completion of chemotherapy. These questionnaires will be administered by a member of the research team who will not be involved in the cognitive behaviour therapy sessions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed